Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Pharmaceutical Benefits Under State Medical Assistance Programs, 1986

This report, part of the Pharmaceutical Benefits Under State Medical Assistance Programs series, is a compilation of data under state medical assistance programs (Title XIX) or state public medical assistance programs (prior Titles of the Social Security Act). It presents a general overview of the characteristics of state programs together with more detailed information on the pharmaceutical benefits provided.

This compilation provides the following information for each state:

  • Recipient groups eligible for benefits
  • Amount expended for drugs per recipient category
  • Characteristics of the State Drug program 
  • Restrictions or limitations on drugs
  • Medicaid or public health officials
  • Pharmacy and medical consultants to the state program
  • Pharmacy and medical advisory committees
  • State medical and pharmaceutical association executives
Blog Post

#TBT: Medicaid’s 50th Anniversary & NPC’s Medicaid Compilation Series

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Newsletter Volume

E.V.I.dently April 2015

MessageThe Health Care Paradigm Shift: Moving From Volume to ValueAs our health care payment and delivery systems shift from volume-based to...
Press Release

State Medicaid Directors Share Views on Comparative Effectiveness Research And Its Impact on Policy in National Pharmaceutical Council Survey

(Washington, DC, April 16, 2015)—A new survey conducted on behalf of the National Pharmaceutical Council (NPC) shows that state Medicaid directors...
Newsletter Volume

E.V.I.dently July 2014

NPC MessageWhen & How Health Decision-Makers Should Consider Individual Patient DifferencesBy Jennifer S. Graff, PharmD, NPC Director of...
Press Release

State Medicaid Directors Share Views on Comparative Effectiveness Research And Its Impact on Policy in National Pharmaceutical Council Survey

(Washington, DC, April 16, 2015)—A new survey conducted on behalf of the National Pharmaceutical Council (NPC) shows that state Medicaid directors...
Blog Post

#TBT: Medicaid’s 50th Anniversary & NPC’s Medicaid Compilation Series

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

#TBT: Medicaid Expansion & Historical Data

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

Evidence, Coverage and Incentives: Challenges in Personalized Medicine

Personalized medicine is greatly changing the way medicine is practiced, as well as how drugs and biologics are developed. Today patients are...

Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research

By choosing "winners and losers," CER drug trials may leave patients who best respond to the "...
Pharmaceutical Benefits Under State Medical Assistance Programs, 2007

Pharmaceutical Benefits Under State Medical Assistance Programs, 2007

This report provides a compilation of data under state medical or state public medical assistance...
  •  
  • 1 of 17
  • >